Back to search

Article

Effect of treatment with GLP-1R agonists on the urinary peptidome of T2DM patients

2023-06-06

Abstract excerpt

Type II diabetes mellitus (T2DM) accounts for approximately 90% of all diabetes mellitus cases in the world. Glucagon-like peptide-1 receptor (GLP-1R) agonists have established an increased capability to target directly or indirectly six core defects associated with T2DM, while, the underlying molecular mechanisms of these pharmacological effects are not fully known. This exploratory study was conducted to analyze...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4fc6a0c3-c287-5ce1-8709-f51364983ce5
DOI
10.22541/au.168607087.71676303/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Effect of treatment with GLP-1R agonists on the urinary peptidome of T2DM patientsDOI 10.22541/au.168607087.71676303/v1
Current progress in pharmacogenomics of Type 2 diabetes: A systemic overview.Semantic proximity
Design and discovery of a highly potent ultralong-acting GLP-1 and glucagon co-agonist for attenuating renal fibrosis by modulating mitochondrial functionSemantic proximity
Urinary Collagen Fragments Are Significantly Altered in Diabetes: A Link to PathophysiologySemantic proximity
The Effect of Metformin Treatment on the Circulating ProteomeSemantic proximity
A mini review on glucagon-like peptide-1 receptor agonists and its role in blood pressure regulationSemantic proximity
Comprehensive Analysis of the Human Urinary Peptidome Using Peptide Clustering Approach Reveals Age- and Gender-Specific PatternsSemantic proximity
Advances in Diagnosis and Management of Diabetes in Children and Adults with Focus on Drugs, Insulin, and Dietary InterventionsSemantic proximity
Re-analysis of Transcriptomic and Proteomic Data Using Multi-Omics Approaches Identifies Biomarkers of Diabetes-Associated Complications in an INS Mutant Pig ModelSemantic proximity
Association of urinary peptides with hypertensionSemantic proximity
Recent advances in understanding the role of glucagon-like peptide 1Semantic proximity
Current therapies and targets for type 2 diabetes mellitusSemantic proximity
Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetesSemantic proximity
Select a neighboring publication to make it the new centre.